Early infections from omicron ‘sister variants’ not more severe, WHO leader says

Health officials have not observed a change in severity among people infected with the omicron “sister variants” BA.4 and BA.5, Maria Van Kerkhove, PhD, COVID-19 technical lead for the World Health Organization, said during an April 13 media briefing.

Advertisement

The WHO began tracking the sublineages — which have been detected in at least five countries — April 11. So far, there are fewer than 200 sequences of the variants available in a global database for analysis. Among these cases, health officials have not detected any changes in the epidemiology of infected people compared with those infected with previous omicron sublineages, according to Dr. Kerkhove. 

“We haven’t really seen any change in that epidemiology; we have not seen a change in severity,” she said.

The WHO is working with experts across the globe to track BA.4 and BA.5 in real time to monitor changes in transmissibility, severity and efficacy with diagnostics and vaccines.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Patient Safety & Outcomes

Advertisement

Comments are closed.